These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 3874373
1. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Ballard PA, Tetrud JW, Langston JW. Neurology; 1985 Jul; 35(7):949-56. PubMed ID: 3874373 [Abstract] [Full Text] [Related]
2. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Langston JW, Ballard P. Can J Neurol Sci; 1984 Feb; 11(1 Suppl):160-5. PubMed ID: 6608979 [Abstract] [Full Text] [Related]
3. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D, Gross C, Lebrun-Grandié P, Bioulac B. C R Seances Soc Biol Fil; 1985 Feb; 179(1):85-97. PubMed ID: 3161601 [Abstract] [Full Text] [Related]
11. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. Proc Natl Acad Sci U S A; 1983 Jul 09; 80(14):4546-50. PubMed ID: 6192438 [Abstract] [Full Text] [Related]
12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK. Neurobiol Dis; 2012 Mar 09; 45(3):1051-67. PubMed ID: 22198503 [Abstract] [Full Text] [Related]
13. Big first scored with nerve diseases. Lewin R. Science; 1989 Aug 04; 245(4917):467-8. PubMed ID: 2502841 [No Abstract] [Full Text] [Related]
14. Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1. Kabel AM, Omar MS, Alhadhrami A, Alharthi SS, Alrobaian MM. Physiol Behav; 2018 May 01; 188():108-118. PubMed ID: 29410018 [Abstract] [Full Text] [Related]